Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells

• Dina Moustafa,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliations Department of Biomedical Informatics and the OSU Comprehensive Cancer Center, Ohio State University, Columbus, OH, United States of America, Faculty of Medicine, Clinical Pathology Department, Zagazig University, Zagazig, Egypt

  ⨯
• Maha R. Abd Elwahed,

  Roles Supervision

  Affiliation Faculty of Medicine, Clinical Pathology Department, Zagazig University, Zagazig, Egypt

  ⨯
• Hanaa H. Elsaid,

  Roles Supervision

  Affiliation Faculty of Medicine, Clinical Pathology Department, Zagazig University, Zagazig, Egypt

  ⨯
• Jeffrey D. Parvin

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Supervision, Visualization, Writing – review & editing

  * E-mail: Jeffrey.Parvin@osumc.edu

  Affiliation Department of Biomedical Informatics and the OSU Comprehensive Cancer Center, Ohio State University, Columbus, OH, United States of America

  https://orcid.org/0000-0001-5616-1928

  ⨯